Vertex Pharmaceuticals Incorporated (NasdaqGS:VRTX) is seeking acquisitions to diversify revenue. Vertex Pharmaceuticals is evaluating potential acquisitions in an attempt to diversify away from cystic fibrosis, according to the sources familiar with the matter.